Merck (MRK) announced the first data presentation from the pivotal 3475A-D77 Phase 3 trial, evaluating the subcutaneous administration of ...

Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

The state-of-the-art manufacturing facility leverages best practices and learnings from across the Merck Manufacturing ... of the shop floor manufacturing process systems – to accelerate new ...

Merck is bracing for the years of sales growth ... the drug for Inflation Reduction Act "government price setting" process in 2026. The negotiated prices would then take effect in January of ...

New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A ...

Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...

Merck KGaA officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the planet ...

Merck added it expects U.S. sales of Keytruda ... The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022. The U.S. government ...

On February 4, Merck released financial results for Q4 ... Dear Seeking Alpha readers, angiogenesis is the process of forming new blood vessels, and its suppression can significantly slow down ...